M84.559D Pathological fracture in neoplastic disease, hip, unspecified, subsequent encounter for fracture with routine healing

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Hip, Unspecified, Subsequent Encounter for Fracture with Routine Healing (ICD-10-CM: M84.559D)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the hip. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the hip's bone integrity, which may involve primary bone tumors or metastatic spread to the hip region. This code is used for a subsequent encounter when the fracture is healing routinely.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the hip, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode hip bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the hip.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to hip sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often severe.
• Swelling or bruising around the hip.
• Difficulty bearing weight or moving the affected leg.
• Visible deformity or shortening of the leg.
• Limited range of motion in the hip joint.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and medical history review. X-rays or CT scans may reveal the fracture and underlying bone abnormalities. MRI or bone scans can help identify the extent of tumor involvement. Biopsy of the affected bone may be performed to confirm the neoplastic cause. Laboratory tests, such as blood work, may assess cancer markers or bone health.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include immobilization with braces or casts, surgical fixation (e.g., plates, screws, or rods), or radiation therapy to reduce tumor burden. Pain management, physical therapy, and cancer-specific treatments (e.g., chemotherapy or targeted therapy) are also part of the care plan.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the fracture's severity. Routine healing of the fracture is expected with appropriate treatment, but long-term outcomes vary. Regular follow-up appointments monitor fracture healing, cancer progression, and functional recovery. Imaging and clinical assessments guide ongoing care.

Complications

• Delayed or nonunion of the fracture.
• Infection at the fracture site or surgical site.
• Nerve or vascular damage near the hip.
• Progression of the underlying cancer.
• Reduced mobility or chronic pain.

Lifestyle & Prevention

• Maintain bone health through adequate calcium and vitamin D intake.
• Engage in weight-bearing exercises to strengthen bones, if approved by a healthcare provider.
• Avoid high-impact activities that may increase fracture risk.
• Follow cancer treatment plans to manage tumor-related bone damage.
• Use assistive devices (e.g., walkers) to reduce hip stress during recovery.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe hip pain, inability to bear weight, or visible deformity. Contact your healthcare provider for worsening pain, swelling, or signs of infection (e.g., fever, redness). Regular follow-up is essential to monitor fracture healing and cancer status.

Tips for Medical Coders

Use this code for a subsequent encounter when the pathological fracture in neoplastic disease of the hip is healing routinely. Document the fracture's location (unspecified hip), the underlying neoplastic disease, and the encounter type (subsequent with routine healing). Ensure clinical documentation supports the fracture's etiology and healing status to justify code assignment.